nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—Goserelin—breast cancer	0.368	1	CrCtD
Cetrorelix—LHCGR—Goserelin—breast cancer	0.223	0.707	CbGbCtD
Cetrorelix—GNRHR—Goserelin—breast cancer	0.0926	0.293	CbGbCtD
Cetrorelix—Degarelix—Goserelin—breast cancer	0.0714	0.315	CrCrCtD
Cetrorelix—Ceruletide—Goserelin—breast cancer	0.0617	0.272	CrCrCtD
Cetrorelix—Nafarelin—Goserelin—breast cancer	0.0491	0.216	CrCrCtD
Cetrorelix—Gonadorelin—Goserelin—breast cancer	0.0446	0.197	CrCrCtD
Cetrorelix—LHCGR—corpus luteum—breast cancer	0.0187	0.712	CbGeAlD
Cetrorelix—LHCGR—adipose tissue—breast cancer	0.00131	0.0496	CbGeAlD
Cetrorelix—LHCGR—female reproductive system—breast cancer	0.0012	0.0456	CbGeAlD
Cetrorelix—LHCGR—female gonad—breast cancer	0.00109	0.0415	CbGeAlD
Cetrorelix—LHCGR—endocrine gland—breast cancer	0.00102	0.0386	CbGeAlD
Cetrorelix—GNRHR—pituitary gland—breast cancer	0.000845	0.0321	CbGeAlD
Cetrorelix—GNRHR—female reproductive system—breast cancer	0.000774	0.0294	CbGeAlD
Cetrorelix—GNRHR—female gonad—breast cancer	0.000704	0.0267	CbGeAlD
Cetrorelix—GNRHR—endocrine gland—breast cancer	0.000655	0.0249	CbGeAlD
Cetrorelix—Contusion—Paclitaxel—breast cancer	0.000149	0.00422	CcSEcCtD
Cetrorelix—Headache—Fluoxymesterone—breast cancer	0.000146	0.00415	CcSEcCtD
Cetrorelix—Erythema—Anastrozole—breast cancer	0.000144	0.00409	CcSEcCtD
Cetrorelix—Immune system disorder—Idarubicin—breast cancer	0.000142	0.00403	CcSEcCtD
Cetrorelix—Cough—Exemestane—breast cancer	0.000141	0.00402	CcSEcCtD
Cetrorelix—Nausea—Fluoxymesterone—breast cancer	0.000138	0.00394	CcSEcCtD
Cetrorelix—Local reaction—Epirubicin—breast cancer	0.000134	0.00381	CcSEcCtD
Cetrorelix—Cough—Ixabepilone—breast cancer	0.000133	0.00379	CcSEcCtD
Cetrorelix—Swelling—Mitoxantrone—breast cancer	0.000131	0.00372	CcSEcCtD
Cetrorelix—Injection site reaction—Paclitaxel—breast cancer	0.000129	0.00366	CcSEcCtD
Cetrorelix—Cough—Anastrozole—breast cancer	0.000126	0.00357	CcSEcCtD
Cetrorelix—Cough—Letrozole—breast cancer	0.000126	0.00357	CcSEcCtD
Cetrorelix—Swelling—Fluorouracil—breast cancer	0.000125	0.00356	CcSEcCtD
Cetrorelix—Local reaction—Doxorubicin—breast cancer	0.000124	0.00352	CcSEcCtD
Cetrorelix—Contusion—Capecitabine—breast cancer	0.000122	0.00347	CcSEcCtD
Cetrorelix—Hypersensitivity—Lapatinib—breast cancer	0.000122	0.00347	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Mitoxantrone—breast cancer	0.000119	0.00339	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Irinotecan—breast cancer	0.000119	0.00339	CcSEcCtD
Cetrorelix—Cough—Raloxifene—breast cancer	0.000119	0.00339	CcSEcCtD
Cetrorelix—Anaphylactic shock—Anastrozole—breast cancer	0.000117	0.00334	CcSEcCtD
Cetrorelix—Anaphylactic shock—Letrozole—breast cancer	0.000117	0.00334	CcSEcCtD
Cetrorelix—Pruritus—Lapatinib—breast cancer	0.000117	0.00333	CcSEcCtD
Cetrorelix—Hypotension—Ixabepilone—breast cancer	0.000117	0.00331	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Gemcitabine—breast cancer	0.000116	0.0033	CcSEcCtD
Cetrorelix—Hypersensitivity—Fulvestrant—breast cancer	0.000112	0.00319	CcSEcCtD
Cetrorelix—Anaphylactic shock—Idarubicin—breast cancer	0.000111	0.00317	CcSEcCtD
Cetrorelix—Redness—Epirubicin—breast cancer	0.00011	0.00312	CcSEcCtD
Cetrorelix—Injection site reaction—Docetaxel—breast cancer	0.000109	0.00311	CcSEcCtD
Cetrorelix—Pruritus—Fulvestrant—breast cancer	0.000108	0.00306	CcSEcCtD
Cetrorelix—Swelling—Paclitaxel—breast cancer	0.000107	0.00303	CcSEcCtD
Cetrorelix—Pruritus—Toremifene—breast cancer	0.000106	0.00302	CcSEcCtD
Cetrorelix—Injection site reaction—Capecitabine—breast cancer	0.000106	0.00301	CcSEcCtD
Cetrorelix—Rash—Lapatinib—breast cancer	0.000104	0.00297	CcSEcCtD
Cetrorelix—Dermatitis—Lapatinib—breast cancer	0.000104	0.00296	CcSEcCtD
Cetrorelix—Headache—Lapatinib—breast cancer	0.000104	0.00295	CcSEcCtD
Cetrorelix—Redness—Doxorubicin—breast cancer	0.000102	0.00289	CcSEcCtD
Cetrorelix—Hot flush—Paclitaxel—breast cancer	0.000101	0.00286	CcSEcCtD
Cetrorelix—Immune system disorder—Melphalan—breast cancer	0.0001	0.00285	CcSEcCtD
Cetrorelix—Menopausal symptoms—Paclitaxel—breast cancer	9.97e-05	0.00284	CcSEcCtD
Cetrorelix—Erythema—Tamoxifen—breast cancer	9.85e-05	0.0028	CcSEcCtD
Cetrorelix—Nausea—Lapatinib—breast cancer	9.83e-05	0.00279	CcSEcCtD
Cetrorelix—Immune system disorder—Goserelin—breast cancer	9.76e-05	0.00278	CcSEcCtD
Cetrorelix—Hypersensitivity—Exemestane—breast cancer	9.74e-05	0.00277	CcSEcCtD
Cetrorelix—Rash—Fulvestrant—breast cancer	9.6e-05	0.00273	CcSEcCtD
Cetrorelix—Dermatitis—Fulvestrant—breast cancer	9.59e-05	0.00273	CcSEcCtD
Cetrorelix—Headache—Fulvestrant—breast cancer	9.53e-05	0.00271	CcSEcCtD
Cetrorelix—Rash—Toremifene—breast cancer	9.47e-05	0.00269	CcSEcCtD
Cetrorelix—Dermatitis—Toremifene—breast cancer	9.46e-05	0.00269	CcSEcCtD
Cetrorelix—Headache—Toremifene—breast cancer	9.41e-05	0.00268	CcSEcCtD
Cetrorelix—Erythema—Goserelin—breast cancer	9.41e-05	0.00267	CcSEcCtD
Cetrorelix—Pruritus—Exemestane—breast cancer	9.35e-05	0.00266	CcSEcCtD
Cetrorelix—Hypersensitivity—Ixabepilone—breast cancer	9.19e-05	0.00261	CcSEcCtD
Cetrorelix—Swelling—Docetaxel—breast cancer	9.04e-05	0.00257	CcSEcCtD
Cetrorelix—Nausea—Fulvestrant—breast cancer	9.04e-05	0.00257	CcSEcCtD
Cetrorelix—Nausea—Toremifene—breast cancer	8.92e-05	0.00254	CcSEcCtD
Cetrorelix—Pruritus—Ixabepilone—breast cancer	8.82e-05	0.00251	CcSEcCtD
Cetrorelix—Swelling—Capecitabine—breast cancer	8.75e-05	0.00249	CcSEcCtD
Cetrorelix—Immune system disorder—Vinorelbine—breast cancer	8.74e-05	0.00249	CcSEcCtD
Cetrorelix—Hypersensitivity—Anastrozole—breast cancer	8.65e-05	0.00246	CcSEcCtD
Cetrorelix—Cough—Tamoxifen—breast cancer	8.59e-05	0.00244	CcSEcCtD
Cetrorelix—Hot flush—Docetaxel—breast cancer	8.53e-05	0.00242	CcSEcCtD
Cetrorelix—Menopausal symptoms—Docetaxel—breast cancer	8.45e-05	0.0024	CcSEcCtD
Cetrorelix—Erythema—Vinorelbine—breast cancer	8.42e-05	0.0024	CcSEcCtD
Cetrorelix—Cough—Melphalan—breast cancer	8.41e-05	0.00239	CcSEcCtD
Cetrorelix—Immune system disorder—Thiotepa—breast cancer	8.35e-05	0.00237	CcSEcCtD
Cetrorelix—Rash—Exemestane—breast cancer	8.33e-05	0.00237	CcSEcCtD
Cetrorelix—Dermatitis—Exemestane—breast cancer	8.33e-05	0.00237	CcSEcCtD
Cetrorelix—Pruritus—Letrozole—breast cancer	8.31e-05	0.00236	CcSEcCtD
Cetrorelix—Pruritus—Anastrozole—breast cancer	8.31e-05	0.00236	CcSEcCtD
Cetrorelix—Headache—Exemestane—breast cancer	8.28e-05	0.00235	CcSEcCtD
Cetrorelix—Hot flush—Capecitabine—breast cancer	8.25e-05	0.00235	CcSEcCtD
Cetrorelix—Hypersensitivity—Idarubicin—breast cancer	8.21e-05	0.00234	CcSEcCtD
Cetrorelix—Cough—Goserelin—breast cancer	8.21e-05	0.00233	CcSEcCtD
Cetrorelix—Menopausal symptoms—Capecitabine—breast cancer	8.18e-05	0.00233	CcSEcCtD
Cetrorelix—Erythema—Thiotepa—breast cancer	8.05e-05	0.00229	CcSEcCtD
Cetrorelix—Anaphylactic shock—Melphalan—breast cancer	7.87e-05	0.00224	CcSEcCtD
Cetrorelix—Rash—Ixabepilone—breast cancer	7.86e-05	0.00224	CcSEcCtD
Cetrorelix—Dermatitis—Ixabepilone—breast cancer	7.86e-05	0.00223	CcSEcCtD
Cetrorelix—Nausea—Exemestane—breast cancer	7.85e-05	0.00223	CcSEcCtD
Cetrorelix—Headache—Ixabepilone—breast cancer	7.81e-05	0.00222	CcSEcCtD
Cetrorelix—Anaphylactic shock—Goserelin—breast cancer	7.68e-05	0.00218	CcSEcCtD
Cetrorelix—Nausea—Ixabepilone—breast cancer	7.41e-05	0.00211	CcSEcCtD
Cetrorelix—Rash—Anastrozole—breast cancer	7.41e-05	0.00211	CcSEcCtD
Cetrorelix—Rash—Letrozole—breast cancer	7.41e-05	0.00211	CcSEcCtD
Cetrorelix—Dermatitis—Anastrozole—breast cancer	7.4e-05	0.0021	CcSEcCtD
Cetrorelix—Dermatitis—Letrozole—breast cancer	7.4e-05	0.0021	CcSEcCtD
Cetrorelix—Injection site reaction—Epirubicin—breast cancer	7.37e-05	0.00209	CcSEcCtD
Cetrorelix—Headache—Letrozole—breast cancer	7.36e-05	0.00209	CcSEcCtD
Cetrorelix—Headache—Anastrozole—breast cancer	7.36e-05	0.00209	CcSEcCtD
Cetrorelix—Hypotension—Melphalan—breast cancer	7.35e-05	0.00209	CcSEcCtD
Cetrorelix—Cough—Vinorelbine—breast cancer	7.35e-05	0.00209	CcSEcCtD
Cetrorelix—Immune system disorder—Irinotecan—breast cancer	7.21e-05	0.00205	CcSEcCtD
Cetrorelix—Hypotension—Goserelin—breast cancer	7.17e-05	0.00204	CcSEcCtD
Cetrorelix—Rash—Idarubicin—breast cancer	7.03e-05	0.002	CcSEcCtD
Cetrorelix—Rash—Raloxifene—breast cancer	7.03e-05	0.002	CcSEcCtD
Cetrorelix—Immune system disorder—Gemcitabine—breast cancer	7.02e-05	0.002	CcSEcCtD
Cetrorelix—Dermatitis—Idarubicin—breast cancer	7.02e-05	0.002	CcSEcCtD
Cetrorelix—Dermatitis—Raloxifene—breast cancer	7.02e-05	0.002	CcSEcCtD
Cetrorelix—Cough—Thiotepa—breast cancer	7.02e-05	0.002	CcSEcCtD
Cetrorelix—Headache—Idarubicin—breast cancer	6.98e-05	0.00199	CcSEcCtD
Cetrorelix—Headache—Raloxifene—breast cancer	6.98e-05	0.00199	CcSEcCtD
Cetrorelix—Nausea—Anastrozole—breast cancer	6.98e-05	0.00198	CcSEcCtD
Cetrorelix—Nausea—Letrozole—breast cancer	6.98e-05	0.00198	CcSEcCtD
Cetrorelix—Erythema—Mitoxantrone—breast cancer	6.95e-05	0.00198	CcSEcCtD
Cetrorelix—Anaphylactic shock—Vinorelbine—breast cancer	6.88e-05	0.00196	CcSEcCtD
Cetrorelix—Injection site reaction—Doxorubicin—breast cancer	6.82e-05	0.00194	CcSEcCtD
Cetrorelix—Erythema—Gemcitabine—breast cancer	6.77e-05	0.00192	CcSEcCtD
Cetrorelix—Erythema—Fluorouracil—breast cancer	6.65e-05	0.00189	CcSEcCtD
Cetrorelix—Hypersensitivity—Chlorambucil—breast cancer	6.65e-05	0.00189	CcSEcCtD
Cetrorelix—Nausea—Idarubicin—breast cancer	6.62e-05	0.00188	CcSEcCtD
Cetrorelix—Nausea—Raloxifene—breast cancer	6.62e-05	0.00188	CcSEcCtD
Cetrorelix—Hypotension—Vinorelbine—breast cancer	6.42e-05	0.00183	CcSEcCtD
Cetrorelix—Pruritus—Chlorambucil—breast cancer	6.39e-05	0.00182	CcSEcCtD
Cetrorelix—Hypersensitivity—Vinblastine—breast cancer	6.1e-05	0.00173	CcSEcCtD
Cetrorelix—Cough—Mitoxantrone—breast cancer	6.06e-05	0.00172	CcSEcCtD
Cetrorelix—Cough—Irinotecan—breast cancer	6.06e-05	0.00172	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Methotrexate—breast cancer	5.94e-05	0.00169	CcSEcCtD
Cetrorelix—Hypersensitivity—Tamoxifen—breast cancer	5.92e-05	0.00168	CcSEcCtD
Cetrorelix—Cough—Gemcitabine—breast cancer	5.91e-05	0.00168	CcSEcCtD
Cetrorelix—Immune system disorder—Paclitaxel—breast cancer	5.88e-05	0.00167	CcSEcCtD
Cetrorelix—Hypersensitivity—Melphalan—breast cancer	5.8e-05	0.00165	CcSEcCtD
Cetrorelix—Hot flush—Epirubicin—breast cancer	5.75e-05	0.00164	CcSEcCtD
Cetrorelix—Menopausal symptoms—Epirubicin—breast cancer	5.7e-05	0.00162	CcSEcCtD
Cetrorelix—Pruritus—Tamoxifen—breast cancer	5.69e-05	0.00162	CcSEcCtD
Cetrorelix—Anaphylactic shock—Irinotecan—breast cancer	5.67e-05	0.00161	CcSEcCtD
Cetrorelix—Anaphylactic shock—Mitoxantrone—breast cancer	5.67e-05	0.00161	CcSEcCtD
Cetrorelix—Erythema—Paclitaxel—breast cancer	5.67e-05	0.00161	CcSEcCtD
Cetrorelix—Hypersensitivity—Goserelin—breast cancer	5.66e-05	0.00161	CcSEcCtD
Cetrorelix—Pruritus—Melphalan—breast cancer	5.57e-05	0.00158	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Epirubicin—breast cancer	5.56e-05	0.00158	CcSEcCtD
Cetrorelix—Anaphylactic shock—Gemcitabine—breast cancer	5.52e-05	0.00157	CcSEcCtD
Cetrorelix—Pruritus—Goserelin—breast cancer	5.43e-05	0.00154	CcSEcCtD
Cetrorelix—Anaphylactic shock—Fluorouracil—breast cancer	5.43e-05	0.00154	CcSEcCtD
Cetrorelix—Nausea—Chlorambucil—breast cancer	5.36e-05	0.00152	CcSEcCtD
Cetrorelix—Hot flush—Doxorubicin—breast cancer	5.32e-05	0.00151	CcSEcCtD
Cetrorelix—Hypotension—Irinotecan—breast cancer	5.3e-05	0.00151	CcSEcCtD
Cetrorelix—Hypotension—Mitoxantrone—breast cancer	5.3e-05	0.00151	CcSEcCtD
Cetrorelix—Menopausal symptoms—Doxorubicin—breast cancer	5.27e-05	0.0015	CcSEcCtD
Cetrorelix—Headache—Vinblastine—breast cancer	5.18e-05	0.00147	CcSEcCtD
Cetrorelix—Hypotension—Gemcitabine—breast cancer	5.16e-05	0.00147	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Doxorubicin—breast cancer	5.14e-05	0.00146	CcSEcCtD
Cetrorelix—Hypotension—Fluorouracil—breast cancer	5.07e-05	0.00144	CcSEcCtD
Cetrorelix—Rash—Tamoxifen—breast cancer	5.07e-05	0.00144	CcSEcCtD
Cetrorelix—Hypersensitivity—Vinorelbine—breast cancer	5.07e-05	0.00144	CcSEcCtD
Cetrorelix—Dermatitis—Tamoxifen—breast cancer	5.06e-05	0.00144	CcSEcCtD
Cetrorelix—Headache—Tamoxifen—breast cancer	5.04e-05	0.00143	CcSEcCtD
Cetrorelix—Immune system disorder—Docetaxel—breast cancer	4.98e-05	0.00142	CcSEcCtD
Cetrorelix—Rash—Melphalan—breast cancer	4.96e-05	0.00141	CcSEcCtD
Cetrorelix—Dermatitis—Melphalan—breast cancer	4.96e-05	0.00141	CcSEcCtD
Cetrorelix—Cough—Paclitaxel—breast cancer	4.94e-05	0.00141	CcSEcCtD
Cetrorelix—Nausea—Vinblastine—breast cancer	4.91e-05	0.0014	CcSEcCtD
Cetrorelix—Pruritus—Vinorelbine—breast cancer	4.86e-05	0.00138	CcSEcCtD
Cetrorelix—Rash—Goserelin—breast cancer	4.84e-05	0.00138	CcSEcCtD
Cetrorelix—Hypersensitivity—Thiotepa—breast cancer	4.84e-05	0.00138	CcSEcCtD
Cetrorelix—Dermatitis—Goserelin—breast cancer	4.84e-05	0.00138	CcSEcCtD
Cetrorelix—Immune system disorder—Capecitabine—breast cancer	4.82e-05	0.00137	CcSEcCtD
Cetrorelix—Headache—Goserelin—breast cancer	4.81e-05	0.00137	CcSEcCtD
Cetrorelix—Erythema—Docetaxel—breast cancer	4.8e-05	0.00137	CcSEcCtD
Cetrorelix—Nausea—Tamoxifen—breast cancer	4.77e-05	0.00136	CcSEcCtD
Cetrorelix—Nausea—Melphalan—breast cancer	4.67e-05	0.00133	CcSEcCtD
Cetrorelix—Erythema—Capecitabine—breast cancer	4.65e-05	0.00132	CcSEcCtD
Cetrorelix—Pruritus—Thiotepa—breast cancer	4.65e-05	0.00132	CcSEcCtD
Cetrorelix—Anaphylactic shock—Paclitaxel—breast cancer	4.62e-05	0.00131	CcSEcCtD
Cetrorelix—Nausea—Goserelin—breast cancer	4.56e-05	0.0013	CcSEcCtD
Cetrorelix—Rash—Vinorelbine—breast cancer	4.34e-05	0.00123	CcSEcCtD
Cetrorelix—Dermatitis—Vinorelbine—breast cancer	4.33e-05	0.00123	CcSEcCtD
Cetrorelix—Hypotension—Paclitaxel—breast cancer	4.32e-05	0.00123	CcSEcCtD
Cetrorelix—Headache—Vinorelbine—breast cancer	4.31e-05	0.00122	CcSEcCtD
Cetrorelix—Cough—Docetaxel—breast cancer	4.19e-05	0.00119	CcSEcCtD
Cetrorelix—Hypersensitivity—Irinotecan—breast cancer	4.18e-05	0.00119	CcSEcCtD
Cetrorelix—Hypersensitivity—Mitoxantrone—breast cancer	4.18e-05	0.00119	CcSEcCtD
Cetrorelix—Rash—Thiotepa—breast cancer	4.14e-05	0.00118	CcSEcCtD
Cetrorelix—Dermatitis—Thiotepa—breast cancer	4.14e-05	0.00118	CcSEcCtD
Cetrorelix—Headache—Thiotepa—breast cancer	4.11e-05	0.00117	CcSEcCtD
Cetrorelix—Nausea—Vinorelbine—breast cancer	4.08e-05	0.00116	CcSEcCtD
Cetrorelix—Cough—Capecitabine—breast cancer	4.06e-05	0.00115	CcSEcCtD
Cetrorelix—Hypersensitivity—Fluorouracil—breast cancer	4e-05	0.00114	CcSEcCtD
Cetrorelix—Anaphylactic shock—Docetaxel—breast cancer	3.92e-05	0.00111	CcSEcCtD
Cetrorelix—Pruritus—Gemcitabine—breast cancer	3.91e-05	0.00111	CcSEcCtD
Cetrorelix—Nausea—Thiotepa—breast cancer	3.9e-05	0.00111	CcSEcCtD
Cetrorelix—Pruritus—Fluorouracil—breast cancer	3.84e-05	0.00109	CcSEcCtD
Cetrorelix—Hypotension—Docetaxel—breast cancer	3.66e-05	0.00104	CcSEcCtD
Cetrorelix—Immune system disorder—Methotrexate—breast cancer	3.59e-05	0.00102	CcSEcCtD
Cetrorelix—Rash—Irinotecan—breast cancer	3.58e-05	0.00102	CcSEcCtD
Cetrorelix—Rash—Mitoxantrone—breast cancer	3.58e-05	0.00102	CcSEcCtD
Cetrorelix—Dermatitis—Mitoxantrone—breast cancer	3.57e-05	0.00102	CcSEcCtD
Cetrorelix—Dermatitis—Irinotecan—breast cancer	3.57e-05	0.00102	CcSEcCtD
Cetrorelix—Headache—Irinotecan—breast cancer	3.55e-05	0.00101	CcSEcCtD
Cetrorelix—Headache—Mitoxantrone—breast cancer	3.55e-05	0.00101	CcSEcCtD
Cetrorelix—Hypotension—Capecitabine—breast cancer	3.55e-05	0.00101	CcSEcCtD
Cetrorelix—Rash—Gemcitabine—breast cancer	3.48e-05	0.00099	CcSEcCtD
Cetrorelix—Dermatitis—Gemcitabine—breast cancer	3.48e-05	0.000989	CcSEcCtD
Cetrorelix—Erythema—Methotrexate—breast cancer	3.46e-05	0.000984	CcSEcCtD
Cetrorelix—Headache—Gemcitabine—breast cancer	3.46e-05	0.000984	CcSEcCtD
Cetrorelix—Rash—Fluorouracil—breast cancer	3.42e-05	0.000974	CcSEcCtD
Cetrorelix—Dermatitis—Fluorouracil—breast cancer	3.42e-05	0.000973	CcSEcCtD
Cetrorelix—Hypersensitivity—Paclitaxel—breast cancer	3.41e-05	0.000969	CcSEcCtD
Cetrorelix—Headache—Fluorouracil—breast cancer	3.4e-05	0.000967	CcSEcCtD
Cetrorelix—Nausea—Mitoxantrone—breast cancer	3.37e-05	0.000958	CcSEcCtD
Cetrorelix—Nausea—Irinotecan—breast cancer	3.37e-05	0.000958	CcSEcCtD
Cetrorelix—Immune system disorder—Epirubicin—breast cancer	3.36e-05	0.000956	CcSEcCtD
Cetrorelix—Nausea—Gemcitabine—breast cancer	3.28e-05	0.000933	CcSEcCtD
Cetrorelix—Pruritus—Paclitaxel—breast cancer	3.27e-05	0.00093	CcSEcCtD
Cetrorelix—Erythema—Epirubicin—breast cancer	3.24e-05	0.000921	CcSEcCtD
Cetrorelix—Nausea—Fluorouracil—breast cancer	3.23e-05	0.000917	CcSEcCtD
Cetrorelix—Immune system disorder—Doxorubicin—breast cancer	3.11e-05	0.000884	CcSEcCtD
Cetrorelix—Cough—Methotrexate—breast cancer	3.02e-05	0.000859	CcSEcCtD
Cetrorelix—Erythema—Doxorubicin—breast cancer	3e-05	0.000852	CcSEcCtD
Cetrorelix—Rash—Paclitaxel—breast cancer	2.92e-05	0.000829	CcSEcCtD
Cetrorelix—Dermatitis—Paclitaxel—breast cancer	2.91e-05	0.000828	CcSEcCtD
Cetrorelix—Headache—Paclitaxel—breast cancer	2.9e-05	0.000824	CcSEcCtD
Cetrorelix—Hypersensitivity—Docetaxel—breast cancer	2.89e-05	0.000821	CcSEcCtD
Cetrorelix—Cough—Epirubicin—breast cancer	2.83e-05	0.000804	CcSEcCtD
Cetrorelix—Anaphylactic shock—Methotrexate—breast cancer	2.83e-05	0.000803	CcSEcCtD
Cetrorelix—Hypersensitivity—Capecitabine—breast cancer	2.8e-05	0.000795	CcSEcCtD
Cetrorelix—Pruritus—Docetaxel—breast cancer	2.77e-05	0.000789	CcSEcCtD
Cetrorelix—Nausea—Paclitaxel—breast cancer	2.75e-05	0.000781	CcSEcCtD
Cetrorelix—Pruritus—Capecitabine—breast cancer	2.69e-05	0.000763	CcSEcCtD
Cetrorelix—Anaphylactic shock—Epirubicin—breast cancer	2.64e-05	0.000752	CcSEcCtD
Cetrorelix—Hypotension—Methotrexate—breast cancer	2.64e-05	0.000751	CcSEcCtD
Cetrorelix—Cough—Doxorubicin—breast cancer	2.62e-05	0.000744	CcSEcCtD
Cetrorelix—Rash—Docetaxel—breast cancer	2.47e-05	0.000703	CcSEcCtD
Cetrorelix—Hypotension—Epirubicin—breast cancer	2.47e-05	0.000702	CcSEcCtD
Cetrorelix—Dermatitis—Docetaxel—breast cancer	2.47e-05	0.000702	CcSEcCtD
Cetrorelix—Headache—Docetaxel—breast cancer	2.46e-05	0.000698	CcSEcCtD
Cetrorelix—Anaphylactic shock—Doxorubicin—breast cancer	2.45e-05	0.000696	CcSEcCtD
Cetrorelix—Rash—Capecitabine—breast cancer	2.39e-05	0.00068	CcSEcCtD
Cetrorelix—Dermatitis—Capecitabine—breast cancer	2.39e-05	0.00068	CcSEcCtD
Cetrorelix—Headache—Capecitabine—breast cancer	2.38e-05	0.000676	CcSEcCtD
Cetrorelix—Nausea—Docetaxel—breast cancer	2.33e-05	0.000662	CcSEcCtD
Cetrorelix—Hypotension—Doxorubicin—breast cancer	2.29e-05	0.00065	CcSEcCtD
Cetrorelix—Nausea—Capecitabine—breast cancer	2.25e-05	0.000641	CcSEcCtD
Cetrorelix—Hypersensitivity—Methotrexate—breast cancer	2.08e-05	0.000592	CcSEcCtD
Cetrorelix—Pruritus—Methotrexate—breast cancer	2e-05	0.000568	CcSEcCtD
Cetrorelix—Hypersensitivity—Epirubicin—breast cancer	1.95e-05	0.000554	CcSEcCtD
Cetrorelix—Pruritus—Epirubicin—breast cancer	1.87e-05	0.000532	CcSEcCtD
Cetrorelix—Hypersensitivity—Doxorubicin—breast cancer	1.8e-05	0.000512	CcSEcCtD
Cetrorelix—Rash—Methotrexate—breast cancer	1.78e-05	0.000507	CcSEcCtD
Cetrorelix—Dermatitis—Methotrexate—breast cancer	1.78e-05	0.000506	CcSEcCtD
Cetrorelix—Headache—Methotrexate—breast cancer	1.77e-05	0.000503	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—AGTR1—breast cancer	1.75e-05	0.000622	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CALCA—breast cancer	1.75e-05	0.000621	CbGpPWpGaD
Cetrorelix—Pruritus—Doxorubicin—breast cancer	1.73e-05	0.000492	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—ITPR1—breast cancer	1.73e-05	0.000615	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RPS6—breast cancer	1.73e-05	0.000614	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF4—breast cancer	1.71e-05	0.000609	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCR4—breast cancer	1.71e-05	0.000607	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL12—breast cancer	1.71e-05	0.000607	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LPAR1—breast cancer	1.7e-05	0.000604	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TLE3—breast cancer	1.7e-05	0.000604	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HEY1—breast cancer	1.68e-05	0.000598	CbGpPWpGaD
Cetrorelix—Nausea—Methotrexate—breast cancer	1.68e-05	0.000477	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PAK1—breast cancer	1.68e-05	0.000596	CbGpPWpGaD
Cetrorelix—Rash—Epirubicin—breast cancer	1.67e-05	0.000474	CcSEcCtD
Cetrorelix—Dermatitis—Epirubicin—breast cancer	1.67e-05	0.000474	CcSEcCtD
Cetrorelix—Headache—Epirubicin—breast cancer	1.66e-05	0.000471	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—DLL1—breast cancer	1.65e-05	0.000586	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TCF7L2—breast cancer	1.65e-05	0.000585	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—AKT2—breast cancer	1.64e-05	0.000583	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CG—breast cancer	1.63e-05	0.000578	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	1.63e-05	0.000578	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIST1H2BK—breast cancer	1.62e-05	0.000575	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIST1H2BC—breast cancer	1.62e-05	0.000575	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRB7—breast cancer	1.6e-05	0.00057	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PDE4D—breast cancer	1.6e-05	0.00057	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CSF2—breast cancer	1.6e-05	0.000568	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NOTCH2—breast cancer	1.59e-05	0.000564	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HSP90AA1—breast cancer	1.59e-05	0.000564	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TAB2—breast cancer	1.58e-05	0.00056	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CD—breast cancer	1.57e-05	0.00056	CbGpPWpGaD
Cetrorelix—Nausea—Epirubicin—breast cancer	1.57e-05	0.000447	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—ITPR1—breast cancer	1.57e-05	0.000558	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CNR2—breast cancer	1.56e-05	0.000556	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—CXCL8—breast cancer	1.56e-05	0.000555	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MMP3—breast cancer	1.56e-05	0.000554	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	1.56e-05	0.000553	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PRL—breast cancer	1.54e-05	0.000549	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AGTR1—breast cancer	1.54e-05	0.000549	CbGpPWpGaD
Cetrorelix—Rash—Doxorubicin—breast cancer	1.54e-05	0.000439	CcSEcCtD
Cetrorelix—Dermatitis—Doxorubicin—breast cancer	1.54e-05	0.000438	CcSEcCtD
Cetrorelix—Headache—Doxorubicin—breast cancer	1.53e-05	0.000436	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—DKK1—breast cancer	1.53e-05	0.000542	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STK11—breast cancer	1.52e-05	0.000541	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ADAM10—breast cancer	1.52e-05	0.000541	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFC—breast cancer	1.51e-05	0.000538	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PLG—breast cancer	1.5e-05	0.000535	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JAG2—breast cancer	1.49e-05	0.00053	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AKT2—breast cancer	1.49e-05	0.000529	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF10—breast cancer	1.48e-05	0.000526	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—WNT1—breast cancer	1.47e-05	0.000523	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PLA2G4A—breast cancer	1.47e-05	0.000521	CbGpPWpGaD
Cetrorelix—Nausea—Doxorubicin—breast cancer	1.45e-05	0.000413	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—CSF2—breast cancer	1.45e-05	0.000515	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CD—breast cancer	1.43e-05	0.000508	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PDGFA—breast cancer	1.43e-05	0.000508	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFBR2—breast cancer	1.41e-05	0.000501	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOTCH4—breast cancer	1.39e-05	0.000495	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ITPR1—breast cancer	1.38e-05	0.000493	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GZMB—breast cancer	1.38e-05	0.000492	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STAT5A—breast cancer	1.38e-05	0.000489	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MMP3—breast cancer	1.38e-05	0.000489	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB4—breast cancer	1.38e-05	0.000489	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CB—breast cancer	1.37e-05	0.000488	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AGTR2—breast cancer	1.34e-05	0.000478	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL2—breast cancer	1.34e-05	0.000478	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SMAD4—breast cancer	1.33e-05	0.000474	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTHLH—breast cancer	1.33e-05	0.000473	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—BMP2—breast cancer	1.33e-05	0.000473	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1R—breast cancer	1.32e-05	0.000471	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—CXCL8—breast cancer	1.32e-05	0.000469	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HES1—breast cancer	1.3e-05	0.000463	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PLA2G4A—breast cancer	1.29e-05	0.00046	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NCOR1—breast cancer	1.29e-05	0.00046	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EDNRB—breast cancer	1.29e-05	0.000458	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF1—breast cancer	1.28e-05	0.000455	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CSF2—breast cancer	1.28e-05	0.000455	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—RAF1—breast cancer	1.28e-05	0.000454	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PGR—breast cancer	1.27e-05	0.000453	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NRG1—breast cancer	1.27e-05	0.000452	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—THBS1—breast cancer	1.27e-05	0.000451	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—H2AFX—breast cancer	1.26e-05	0.000448	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—IL2—breast cancer	1.26e-05	0.000448	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—E2F1—breast cancer	1.25e-05	0.000445	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CB—breast cancer	1.25e-05	0.000443	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FLT1—breast cancer	1.21e-05	0.00043	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF3—breast cancer	1.2e-05	0.000428	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SQSTM1—breast cancer	1.2e-05	0.000428	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SPP1—breast cancer	1.2e-05	0.000428	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CG—breast cancer	1.2e-05	0.000426	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—CXCL8—breast cancer	1.2e-05	0.000426	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB3—breast cancer	1.19e-05	0.000423	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JAG1—breast cancer	1.19e-05	0.000423	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGFR2—breast cancer	1.19e-05	0.000422	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOTCH3—breast cancer	1.18e-05	0.000421	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PARP1—breast cancer	1.18e-05	0.000421	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CALCA—breast cancer	1.17e-05	0.000416	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RPS6—breast cancer	1.16e-05	0.000411	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF4—breast cancer	1.15e-05	0.000408	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL2—breast cancer	1.14e-05	0.000407	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCR4—breast cancer	1.14e-05	0.000406	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL12—breast cancer	1.14e-05	0.000406	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TERT—breast cancer	1.14e-05	0.000405	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PAK1—breast cancer	1.12e-05	0.000399	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGFR1—breast cancer	1.11e-05	0.000394	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TCF7L2—breast cancer	1.1e-05	0.000392	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AKT2—breast cancer	1.1e-05	0.00039	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIF1A—breast cancer	1.09e-05	0.000388	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CG—breast cancer	1.09e-05	0.000387	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LEP—breast cancer	1.06e-05	0.000378	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HSP90AA1—breast cancer	1.06e-05	0.000378	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOTCH2—breast cancer	1.06e-05	0.000378	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CAV1—breast cancer	1.05e-05	0.000375	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CD—breast cancer	1.05e-05	0.000375	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KDR—breast cancer	1.04e-05	0.000371	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PRL—breast cancer	1.03e-05	0.000367	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AGTR1—breast cancer	1.03e-05	0.000367	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STK11—breast cancer	1.02e-05	0.000362	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ADAM10—breast cancer	1.02e-05	0.000362	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ESR1—breast cancer	1.02e-05	0.000361	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PLG—breast cancer	1.01e-05	0.000358	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FN1—breast cancer	1e-05	0.000357	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKT2—breast cancer	9.96e-06	0.000354	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NFKBIA—breast cancer	9.92e-06	0.000353	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF10—breast cancer	9.91e-06	0.000352	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NOTCH1—breast cancer	9.82e-06	0.000349	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CG—breast cancer	9.6e-06	0.000342	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KIT—breast cancer	9.6e-06	0.000342	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APC—breast cancer	9.6e-06	0.000342	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CD—breast cancer	9.57e-06	0.00034	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PDGFA—breast cancer	9.56e-06	0.00034	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGF—breast cancer	9.49e-06	0.000338	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFBR2—breast cancer	9.42e-06	0.000335	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ITPR1—breast cancer	9.27e-06	0.00033	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB4—breast cancer	9.21e-06	0.000328	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MMP3—breast cancer	9.21e-06	0.000328	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STAT5A—breast cancer	9.21e-06	0.000328	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—MAPK3—breast cancer	9.2e-06	0.000327	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CB—breast cancer	9.18e-06	0.000327	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—BRAF—breast cancer	9.03e-06	0.000321	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SMAD4—breast cancer	8.92e-06	0.000317	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1R—breast cancer	8.86e-06	0.000315	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCL8—breast cancer	8.82e-06	0.000314	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1—breast cancer	8.79e-06	0.000313	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKT2—breast cancer	8.79e-06	0.000313	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—EGFR—breast cancer	8.75e-06	0.000311	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HES1—breast cancer	8.71e-06	0.00031	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PLA2G4A—breast cancer	8.66e-06	0.000308	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NCOR1—breast cancer	8.66e-06	0.000308	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CSF2—breast cancer	8.56e-06	0.000305	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF1—breast cancer	8.56e-06	0.000305	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—RAF1—breast cancer	8.54e-06	0.000304	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NRG1—breast cancer	8.5e-06	0.000302	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CD—breast cancer	8.44e-06	0.0003	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—H2AFX—breast cancer	8.44e-06	0.0003	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—IL2—breast cancer	8.43e-06	0.0003	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—E2F1—breast cancer	8.38e-06	0.000298	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CA—breast cancer	8.36e-06	0.000297	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SERPINE1—breast cancer	8.35e-06	0.000297	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CB—breast cancer	8.34e-06	0.000297	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—KRAS—breast cancer	8.27e-06	0.000294	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SPP1—breast cancer	8.05e-06	0.000286	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCL8—breast cancer	8.01e-06	0.000285	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NOS3—breast cancer	7.97e-06	0.000284	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB3—breast cancer	7.96e-06	0.000283	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGFR2—breast cancer	7.95e-06	0.000283	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL2—breast cancer	7.66e-06	0.000272	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TERT—breast cancer	7.63e-06	0.000271	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CA—breast cancer	7.59e-06	0.00027	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MDM2—breast cancer	7.56e-06	0.000269	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RAF1—breast cancer	7.54e-06	0.000268	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RELA—breast cancer	7.5e-06	0.000267	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB2—breast cancer	7.46e-06	0.000265	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGFR1—breast cancer	7.41e-06	0.000264	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MTOR—breast cancer	7.36e-06	0.000262	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CB—breast cancer	7.36e-06	0.000262	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIF1A—breast cancer	7.3e-06	0.00026	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LEP—breast cancer	7.12e-06	0.000253	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL8—breast cancer	7.07e-06	0.000252	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CAV1—breast cancer	7.06e-06	0.000251	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—HRAS—breast cancer	7.03e-06	0.00025	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KDR—breast cancer	6.98e-06	0.000248	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1B—breast cancer	6.91e-06	0.000246	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—AKT1—breast cancer	6.83e-06	0.000243	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ESR1—breast cancer	6.8e-06	0.000242	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP3—breast cancer	6.77e-06	0.000241	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL2—breast cancer	6.76e-06	0.00024	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL6—breast cancer	6.72e-06	0.000239	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FN1—breast cancer	6.72e-06	0.000239	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NFKBIA—breast cancer	6.64e-06	0.000236	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CCND1—breast cancer	6.59e-06	0.000234	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—JUN—breast cancer	6.57e-06	0.000234	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOTCH1—breast cancer	6.57e-06	0.000234	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CTNNB1—breast cancer	6.52e-06	0.000232	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APC—breast cancer	6.43e-06	0.000229	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CG—breast cancer	6.43e-06	0.000229	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KIT—breast cancer	6.43e-06	0.000229	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MMP9—breast cancer	6.4e-06	0.000228	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1A—breast cancer	6.37e-06	0.000227	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTEN—breast cancer	6.36e-06	0.000226	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGF—breast cancer	6.35e-06	0.000226	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAPK8—breast cancer	6.22e-06	0.000221	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AKT1—breast cancer	6.2e-06	0.000221	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAPK3—breast cancer	6.16e-06	0.000219	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—BRAF—breast cancer	6.04e-06	0.000215	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SRC—breast cancer	5.9e-06	0.00021	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1—breast cancer	5.89e-06	0.000209	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKT2—breast cancer	5.88e-06	0.000209	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—EGFR—breast cancer	5.86e-06	0.000208	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFA—breast cancer	5.74e-06	0.000204	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STAT3—breast cancer	5.69e-06	0.000202	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CD—breast cancer	5.65e-06	0.000201	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CA—breast cancer	5.6e-06	0.000199	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SERPINE1—breast cancer	5.59e-06	0.000199	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—KRAS—breast cancer	5.53e-06	0.000197	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAPK3—breast cancer	5.43e-06	0.000193	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOS3—breast cancer	5.34e-06	0.00019	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MYC—breast cancer	5.28e-06	0.000188	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFB1—breast cancer	5.27e-06	0.000188	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGFR—breast cancer	5.17e-06	0.000184	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CA—breast cancer	5.08e-06	0.000181	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MDM2—breast cancer	5.06e-06	0.00018	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RAF1—breast cancer	5.05e-06	0.000179	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RELA—breast cancer	5.02e-06	0.000179	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB2—breast cancer	4.99e-06	0.000178	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MTOR—breast cancer	4.93e-06	0.000175	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CB—breast cancer	4.93e-06	0.000175	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KRAS—breast cancer	4.88e-06	0.000174	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL8—breast cancer	4.73e-06	0.000168	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—HRAS—breast cancer	4.7e-06	0.000167	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1B—breast cancer	4.62e-06	0.000164	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AKT1—breast cancer	4.57e-06	0.000163	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP3—breast cancer	4.53e-06	0.000161	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL2—breast cancer	4.52e-06	0.000161	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL6—breast cancer	4.5e-06	0.00016	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CA—breast cancer	4.49e-06	0.00016	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CCND1—breast cancer	4.41e-06	0.000157	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUN—breast cancer	4.4e-06	0.000157	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CTNNB1—breast cancer	4.37e-06	0.000155	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—breast cancer	4.34e-06	0.000154	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MMP9—breast cancer	4.28e-06	0.000152	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1A—breast cancer	4.27e-06	0.000152	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTEN—breast cancer	4.26e-06	0.000151	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAPK8—breast cancer	4.16e-06	0.000148	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKT1—breast cancer	4.15e-06	0.000148	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HRAS—breast cancer	4.15e-06	0.000148	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL6—breast cancer	3.97e-06	0.000141	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SRC—breast cancer	3.95e-06	0.00014	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFA—breast cancer	3.84e-06	0.000137	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STAT3—breast cancer	3.81e-06	0.000135	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKT1—breast cancer	3.66e-06	0.00013	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAPK3—breast cancer	3.64e-06	0.000129	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MYC—breast cancer	3.54e-06	0.000126	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFB1—breast cancer	3.53e-06	0.000126	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGFR—breast cancer	3.46e-06	0.000123	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KRAS—breast cancer	3.27e-06	0.000116	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CA—breast cancer	3e-06	0.000107	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—breast cancer	2.91e-06	0.000103	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HRAS—breast cancer	2.78e-06	9.88e-05	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL6—breast cancer	2.66e-06	9.46e-05	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKT1—breast cancer	2.45e-06	8.73e-05	CbGpPWpGaD
